ミズーリ州におけるリンパ腫の臨床試験
ミズーリ州内の拠点で、リンパ腫に関する17件の研究が参加者を募集しています。
ミズーリ州内の都市
公式研究テキスト（英語）
A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma
- Washington University School of Medicine - Oncology Hospital - Public, St Louis
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/30更新 · NCT07192471A Study of the Efficacy and Safety of Lisocabtagene Maraleucel (Liso-cel) as First-Line Therapy in Adults With Transplant-Ineligible Primary Central Nervous System Lymphoma
- Washington University School of Medicine in St. Louis, St Louis
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/30更新 · NCT07015242A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
- Washington University School of Medicine in St. Louis, St Louis
被験者募集中第1/2相
25歳以下 · 全性別 · 2026/09/25更新 · NCT04094610Testing the Addition of an Anti-cancer Drug, Lenalidomide, to the Usual Combination Chemotherapy Treatment ("EPOCH") for Adult T-Cell Leukemia-Lymphoma (ATLL)
- Siteman Cancer Center at Saint Peters Hospital, City of Saint Peters
- Siteman Cancer Center at West County Hospital, Creve Coeur
- Washington University School of Medicine, St Louis
- 他1件
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/23更新 · NCT04301076Collection of Tissue Samples for Cancer Research
- Washington University - St. Louis, St Louis
被験者募集中観察研究
2 Months · 全性別 · 2026/09/16更新 · NCT00900198CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma
- Children's Mercy Hospitals and Clinics, Kansas City
- Washington University School of Medicine, St Louis
被験者募集中第1/2相
12 Months – 21 Years · 全性別 · 2026/09/11更新 · NCT04870944TLN-121 in Relapsed or Refractory Non-Hodgkin Lymphomas
- Washington University School of Medicine, St Louis
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/04更新 · NCT07082803A Study to Evaluate Glofitamab as a Single Agent vs. Investigator's Choice in Participants With Relapsed/Refractory Mantle Cell Lymphoma
- St. Luke's Hospital, Chesterfield
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/03更新 · NCT06084936A Phase 1 Study of UB-VV111 With and Without Rapamycin in Relapsed/Refractory CD19+ B-cell Malignancies
- Washington University School of Medicine/Siteman Cancer Center, St Louis
被験者募集中第1相
18歳以上 · 全性別 · 2026/08/17更新 · NCT06528301DALY II USA/ MB-CART2019.1 for DLBCL
- Washington University, St. Louis, St Louis
被験者募集中第2相
18歳以上 · 全性別 · 2026/07/13更新 · NCT04792489An AI-Generated, Personalized Question Prompt List Intervention for Patients With Hematologic Cancers
- Washington University School of Medicine, St Louis
被験者募集中
18歳〜99歳 · 全性別 · 2026/06/01更新 · NCT07226934Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
- Washington University School of Medicine, St Louis
被験者募集中観察研究
全年齢 · 全性別 · 2026/05/18更新 · NCT01790152Post-Op Pain Control for Prophylactic Intramedullary Nailing.
- Saint Louis University, St Louis
被験者募集中第3相
18歳以上 · 全性別 · 2026/04/22更新 · NCT03823534BRAZAN: A Randomized Phase 2 Study of Bendamustine, Rituximab, Cytarabine (AraC) Induction With Zanubrutinib (BRAZAN) Followed by Zanubrutinib/Rituximab +/- Sonrotoclax Maintenance in Treatment-Naïve Mantle Cell Lymphoma
- Washington University, St Louis
被験者募集中第2相
18歳以上 · 全性別 · 2026/02/20更新 · NCT06854003Geriatric Evaluation and Management With Survivorship Health Education for Older Survivors of Cancer, GEM-S Trial
- Lake Regional Hospital, Osage Beach
被験者募集中第3相健康なボランティア歓迎
18歳以上 · 全性別 · 2026/01/13更新 · NCT05006482A Safety and Efficacy Study Evaluating CTX112 in Subjects With Relapsed or Refractory B-Cell Malignancies
- Washington University, St Louis
被験者募集中第1/2相
18歳以上 · 全性別 · 2025/11/14更新 · NCT05643742A Randomized Phase II Study Of Bruton Tyrosine Kinase Inhibitor With Or Without Venetoclax In Veterans With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
- Kansas City VA Medical Center, Kansas City, MO, Kansas City
被験者募集中第2相
18歳〜80歳 · 全性別 · 2025/10/14更新 · NCT06520098ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。